Skip to main content

Table 2 Numbers of trials by funding source and trial design (RCT or non-RCT)

From: How Can the Evidence from Global Large-scale Clinical Trials for Cardiovascular Diseases be Improved?

Funding source Number of trials Proportion of RCT (%)
  RCT Non-RCT Total  
Industry 142 62 204 (59.3%) 69.6
Academic 79 43 122 (35.5%) 64.8
Government 44 11 55 (16.0%) 80.0
Foundation 28 4 32 (9.3%) 87.5
Other 37 11 48 (14.0%) 77.1
Total 243 101 344 (100%) 70.6